Author

A. Bag

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A. Schultz· 1 shared D. Adeegbe· 1 shared L. Cen· 1 shared S. Bhimani· 1 shared W. Dominguez· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Schultz

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The immunomodulatory properties of the HDAC6 inhibitor ACY241 supports robust anti-tumor response in NSCLC when coupled with the chemotherapy drug Oxaliplatin

A. Bag, A. Schultz, S. Bhimani, W. Dominguez, L. Cen, D. Adeegbe

This study shows that ACY241, an HDAC6 inhibitor, enhances anti-tumor responses in NSCLC when combined with Oxaliplatin by modulating tumor immune cells.

bioRxiv · Oct 1, 2021 · PreprintImmunology